Radiofrequency ablation of high-grade dysplastic nodules
Open Access
- 2 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 54 (6) , 2005-2011
Abstract
High-grade dysplastic nodules (HGDNs) are known to be premalignant lesions of hepatocellular carcinoma (HCC). We devised a model to estimate the long-term survival benefit of treating HGDNs by radiofrequency ablation (RFA) (Group I), as compared with regular follow-up and timely treatment by resection (Group II). A hypothetical 60-year-old compensated patient with cirrhosis was assumed. The system being modeled was assumed to be a simple Markov process, and state transition probabilities were given as parameters. Data used for simulation were obtained by a systematic review of the literature. The reported overall malignant transformation rates of HGDNs ranged from 12.5% to 80.8%, and were assumed to be 20%, 50%, and 80% using the best, moderate, and worst scenarios for Group II, respectively. The 5-year overall survival benefit of Group I compared with Group II was calculated by summing the detrimental effect of overtreatment and the beneficial effects of avoiding operative mortality. When the overall malignant transformation rate was set at 20%, 50%, or 80% the expected additional 5-year overall survival benefits of Group I compared with Group II were −0.05%, 0.20%, and 0.47%, respectively, and the corresponding additional 10-year overall survival benefits were 0.03%, 0.33%, and 0.55%, respectively. One-way sensitivity analysis showed that Group I was preferable to Group II in terms of 5-year overall survival when the 5-year overall malignant transformation rate was greater than 25.9%. Conclusion: No definite evidence indicates that the treatment of HGDNs by RFA provides additional long-term overall survival benefit as compared with regular follow-up and timely treatment. The findings of the present study concur with the present American Association for the Study of Liver Diseases guidelines. (Hepatology 2011 )Keywords
This publication has 66 references indexed in Scilit:
- Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablationHepatology International, 2009
- Multistep human hepatocarcinogenesis: correlation of imaging with pathologyJournal of Gastroenterology, 2009
- Recent advances in the natural history of hepatocellular carcinomaCarcinogenesis, 2008
- Multistep hepatocarcinogenesis from a dysplastic nodule to well-differentiated hepatocellular carcinoma in a patient with alcohol-related liver cirrhosisWorld Journal of Gastroenterology, 2007
- Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosisCancer, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆Gastroenterology, 2004
- Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma developmentJournal of Hepatology, 2003
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- Malignant transformation of adenomatous hyperplasia to hepatocellular carcinomaThe Lancet, 1990